<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Illness and Diseases</title>
	<atom:link href="http://www.diseases-illness.com/feed" rel="self" type="application/rss+xml" />
	<link>http://www.diseases-illness.com</link>
	<description></description>
	<lastBuildDate>Fri, 26 Mar 2021 06:46:54 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.0.38</generator>
	<item>
		<title>Canadian Pharmacy: Generic Viagra Revolution Is On Its Way</title>
		<link>http://www.diseases-illness.com/canadian-pharmacy-generic-viagra-revolution-is-on-its-way.html</link>
		<comments>http://www.diseases-illness.com/canadian-pharmacy-generic-viagra-revolution-is-on-its-way.html#comments</comments>
		<pubDate>Fri, 03 Jun 2016 11:08:12 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Medications]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/?p=668</guid>
		<description><![CDATA[Canadian Pharmacy is reimagining the shopping experience of buying drugs on the web, and it seems like the old days when buying meds online was associated with numerous risks are about to sink into oblivion. The neoteric platform that has stepped into the game in the 4th quarter of 2015 and has gained some good [&#8230;]]]></description>
				<content:encoded><![CDATA[<p style="text-align: justify;">Canadian Pharmacy is reimagining the shopping experience of buying drugs on the web, and it seems like the old days when buying meds online was associated with numerous risks are about to sink into oblivion. The neoteric platform that has stepped into the game in the 4th quarter of 2015 and has gained some good press and positive feedback already, is looking to eliminate the long-lasting weak points through savvy technologies and customer-oriented business approaches. What does it mean for a common buyer? Actually, like the big fish booking.com or UBER, Online Pharmacy is not involved in direct sales of drugs, and neither it is associated or affiliated with the manufacturing, sales or marketing pharmaceutical companies.</p>
<p style="text-align: justify;"><a href="https://www.canadianhealthmall.com">When you drop in at Canadian Pharmacy</a> for highly demanded meds like Viagra, you can be sure that you’ve got risks protected from every angle. The unparalleled security of your choice is ensured by the tough verification process each drugstore is required to pass through before getting an approval to share the offers on the platform. Canadian Pharmacy Mall authorities know all the underwater rocks of drugs sales, and to exclude any issues associated with quality they initiated comprehensive business scanning, scrutinizing every aspect of business functioning (from drugs supplies to delivery and shipping routine). Providing access to quality, cheap meds for millions, the service goes beyond the standard business model in favour of more comprehensive strategic development. And this is what it means for common customers.</p>
<p style="text-align: justify;"><img class="aligncenter wp-image-673" src="http://www.diseases-illness.com/wp-content/uploads/2016/06/General-Physician-Doctors-300x200.jpg" alt="Canadian Pharmacy: Generic Viagra Revolution Is On Its Way" width="400" height="267" /></p>
<h2 style="text-align: center;"><strong>The pricing going through the floor</strong></h2>
<p style="text-align: justify;">Online Pharmacy prefers to cooperate with online drugstores that work directly with manufacturers: this fact is reducing the risks of dealing with counterfeit products, as well as positively affects the total price. Focusing on erectile dysfunction products and knowing the real manufacturing costs the platform doesn’t allow its partners to manipulate the pricing &#8211; as a result you can buy Viagra starting from as low as $1.90 per unit (the total sum may be even lower). Against the background of branded preparations, <a href="https://www.canadianhealthmall.com/viagra-generic" target="_blank">Generic Viagra</a> will cost you 9 &#8211; 10 times less. And this is where the benefits are not over &#8211; unlike in numerous online drugstores, the cost of shipping could easily jump up to $50 &#8211; $80 or even more for expedited options. At Canadian Pharmacy you get a free of charge shipping for all the orders over $200 (in addition, you’ll have your order upgraded with an advanced protection for no cost as well).</p>
<h3 style="text-align: center;"><strong>The new page in customer service strategy</strong></h3>
<p style="text-align: justify;">Well, <a href="http://www.medicinenet.com/erectile_dysfunction_ed_impotence/article.htm" target="_blank">erectile dysfunction treatment</a> is not limited to taking the most powerful drugs &#8211; this is where a holistic effect is absolutely crucial. The holistic effect in platform development is another strong suit you will definitely appreciate &#8211; these guys run a comprehensive knowledgebase on various aspects of ED treatment. It is comprised of numerous professional articles, reviews, statistics reports and experimental studies overviews &#8211; everything you need to know about the ED and super-efficient recovery is gathered under one roof at your convenience.</p>
<p style="text-align: justify;"><strong>In addition, you can always count on free professional consultations.</strong> Yes, you don’t have to pay to get an expert advice on the choice of anti-ED agent, the best ways to deal with a sophisticated problem or finding the way to avoid ED issues in the future. Selfsame, you can get in touch with customer support and get assisted in a timely fashion in case of any problems. Finally, you can always count on quick delivery &#8211; all the partners are required to offer at least 1 expedited shipping option that takes 8 &#8211; 14 days; plus all the orders are delivered to your door in discreet packages, so even the courier doesn’t know what’s inside the parcel.</p>
<p style="text-align: justify;"><strong>The longer you stay with Canadian Pharmacy, the more benefits you get.</strong> All the customers automatically enrol in a loyalty program, and get bigger discounts and dedicated support over the time. Canadian Pharmacy Mall is all about fresh and modern experience &#8211; you should definitely give it a try.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/canadian-pharmacy-generic-viagra-revolution-is-on-its-way.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Make the Right Choice of Generic Viagra Online and Choose it at Canadian Pharmacy</title>
		<link>http://www.diseases-illness.com/make-the-right-choice-of-generic-viagra-online-and-choose-it-at-canadian-pharmacy.html</link>
		<comments>http://www.diseases-illness.com/make-the-right-choice-of-generic-viagra-online-and-choose-it-at-canadian-pharmacy.html#comments</comments>
		<pubDate>Wed, 03 Feb 2016 10:40:58 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Medications]]></category>
		<category><![CDATA[Canadian pharmacy]]></category>
		<category><![CDATA[generic viagra]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/?p=655</guid>
		<description><![CDATA[What do you usually do when you try to get such medicine as generic Viagra online? Do you stand up, grab your wallet and rush to the nearest land-based pharmacy? That is quite doubtful. As any other person absorbing all innovations like a sponge you will cover the single meter to your PC and look [&#8230;]]]></description>
				<content:encoded><![CDATA[<p style="text-align: justify;">What do you usually do when you try to get such medicine as generic Viagra online? Do you stand up, grab your wallet and rush to the nearest land-based pharmacy? That is quite doubtful. As any other person absorbing all innovations like a sponge you will cover the single meter to your PC and look for options of getting one on the Web first. It is simple, and it does not require more energetic or financial expenses. Even more than that. You will surely find it extremely funny to look through various ready-witted feedback and comments on Viagra.</p>
<p style="text-align: justify;"><em><strong>Read Also:</strong></em> Viagra online in Canadian Pharmacy &#8211; http://www.canadianhealthcaremalll.com/generic-viagra-online</p>
<p style="text-align: justify;">Discovering something new on the Internet it is advisable that you paid special attention to the hints of what is considered the right steps to take when you choose generic Viagra online.</p>
<h2 style="text-align: center;">Tips on Choosing Generic Viagra Online</h2>
<p><img class="aligncenter  wp-image-656" src="http://www.diseases-illness.com/wp-content/uploads/2016/01/Generic-Viagra.jpg" alt="Generic Viagra" width="415" height="415" /></p>
<p style="text-align: justify;">When we are talking about online shopping, the very first thought that comes to one&#8217;s mind is that buying things online is not quite safe. But this is not the thing that you should worry about when you cooperate with Canadian Health&amp;Care Pharmacy as there is no safer place to choose generic Viagra online. And this is your main tip keeping to which you will always be happy with your online shopping.</p>
<p style="text-align: justify;">A reliable drugs vendor is all you might want when you deal with online shopping for drugs. Canadian Health and Care Pharmacy offers the following benefits for you to get the most out of your shopping for medications:</p>
<ul>
<li style="text-align: justify;">Total safety of your personal data (credit card data, private information).</li>
<li style="text-align: justify;">High quality of all the medicines that you buy.</li>
<li style="text-align: justify;">Reasonable prices which are guaranteed by the pharmacy.</li>
<li style="text-align: justify;">On time deliveries.</li>
<li style="text-align: justify;">Polite and careful attitude.</li>
<li style="text-align: justify;">Special offers to new and loyal customers.</li>
</ul>
<h3 style="text-align: center;">Unconditional Quality of Generic Viagra Provided</h3>
<p style="text-align: justify;">Before you stick to Canadian Pharmacy Mall and make your first order of generic Viagra, you&#8217;ll definitely want to be aware of all the necessary facts about this ED medication and its features. Generic Viagra is what you really need because:</p>
<ul>
<li style="text-align: justify;">It causes no side effects at all, and this fact was proven by many customers who took generic Viagra 50 and 100 mg.</li>
<li style="text-align: justify;">It is highly effective; however, don&#8217;t think of it as a cure from impotence, because any ED medication starts working only when there is sexual stimulation.</li>
<li style="text-align: justify;">It is highly recommended to men of all ages who are currently suffering from erectile dysfunction.</li>
</ul>
<p style="text-align: justify;">Now that you have found out enough and are sure Canadian Health&amp;Care Pharmacy is the pharmacy you have been looking for, this is high time you made your order. You could check Canadian Pharmacy site: http://www.canadianhealthcaremalll.com.</p>
<h3 style="text-align: center;">Benefits of Canadian Pharmacy</h3>
<p style="text-align: justify;">Generic Canadian Pharmacy is a trustworthy online pharmacy service with a professional staff consisting of pharmacists and health care providers. They are able to deal with any arisen question and provide you with necessary assistance whenever you need it. Generic Viagra that you can buy here is an undoubtedly effective product for poor erection. However, this is not the only product you can order as we also offer medications and supplements for treating other diseases that often lead to erectile dysfunction.</p>
<p style="text-align: justify;">Lack of vitamins can be easily eliminated with a complex of vitamins promoted at reasonable rates. You can finally find a solution and get rid of insomnia because of anxiety and too much of work. Just look through the list of medications available to treat these issues. Viruses and infections can be fought back with high quality antibiotics that are able to eliminate all kinds of infections. You don&#8217;t need to go somewhere else anymore, as a variety of the best quality and cheap medicines can be bought right from the comfort of your home.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/make-the-right-choice-of-generic-viagra-online-and-choose-it-at-canadian-pharmacy.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Anticoagulant Treatment &#8211; Canadian Health&amp;Care Mall researches</title>
		<link>http://www.diseases-illness.com/anticoagulant-treatment-canadian-healthcare-mall-researches.html</link>
		<comments>http://www.diseases-illness.com/anticoagulant-treatment-canadian-healthcare-mall-researches.html#comments</comments>
		<pubDate>Mon, 21 Sep 2015 11:27:08 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Anticoagulant Treatment]]></category>
		<category><![CDATA[Health&Care Mall Articles]]></category>
		<category><![CDATA[canadian health&care mall]]></category>
		<category><![CDATA[Warfarin regimens]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/hemorrhagic-complications-of-anticoagulant-treatment-part-3.html</guid>
		<description><![CDATA[Warfarin regimens (targeted INR &#60; 2.0) have been investigated and found to be safe in the primary prevention of thrombosis in patients with malignancy. In two randomized trials in patients with malignancy, warfarin therapy, 1 mg/d of warfarin and 1 mg/d for 6 weeks followed by adjustment to an INR of 1.3 to 1.9, did not increase the frequency [&#8230;]]]></description>
				<content:encoded><![CDATA[<p>Warfarin regimens (targeted INR &lt; 2.0) have been investigated and found to be safe in the primary prevention of thrombosis in patients with malignancy. In two randomized trials in patients with malignancy, warfarin therapy, 1 mg/d of warfarin and 1 mg/d for 6 weeks followed by adjustment to an INR of 1.3 to 1.9, did not increase the frequency of hemorrhage while still preventing thrombosis.</p>
<p>Increased variation in the anticoagulant effect, manifested by variation in the INR, is associated with an increased frequency of hemorrhage independent of the mean INR. This effect is probably attributable to increased frequency and degree of marked elevations in the INR. Approaches to improve anticoagulant control (minimize INR fluctuations) could improve the safety and effectiveness of vitamin K antagonists. Anticoagulation management services (AMSs) or clinics and point-of-care INR testing are two such approaches. Two recent randomized trials did not show a difference in quality of anticoagulant control or bleeding between AMSs and routine medical care. Results from four observational studies showed AMSs were beneficial and associated with less bleeding than usual care.</p>
<p>Check Canadian Health&amp;Care Mall websites for more information:<br />
1. http://www.canadianhealthcaremalll.com<br />
2. <a href="http://www.acanadianhealthcaremall.com">http://www.acanadianhealthcaremall.com</a></p>
<p>Point-of-care testing with either patient self-testing or patient self-management is another model for potentially improving outcomes, as well as convenience. Patient self-testing provided better quality of anticoagulation control compared to routine medical care in one trial (time in therapeutic range, 56% vs 32% [p &lt; 0.001], and bleeding, 5.6% vs 12%, respectively [p = 0.05] after 6 months of follow-up), but no convincing difference compared with AMSs in two other studies. Similarly, studies of patient self-management report better quality of anticoagulant control compared to routine medical care vs AMSs. Thus, no definite recommendations about the optimal approach for maintaining anticoagulant control can be made.</p>
<p>1.1.1 Patient characteristics by Canadian Health&amp;Care Mall Team</p>
<p>The risk of major bleeding during warfarin therapy can be related to specific comorbid conditions or patient characteristics. An increasing body of evidence supports age as an independent risk factor for major bleeding. For example, Pengo et al evaluated the relationship of age and other risk factors to the incidence of major bleeding. Major bleeding occurred more frequently in patients &gt; 75 years of age (5.1%/yr) than in younger patients (1%/yr). Multivariate analysis indicated that age &gt; 75 years was the only variable independently related to primary bleeding (ie, bleeding unrelated to organic lesion). Also, risk for intracranial hemorrhage may be increased among older patients, especially those &gt; 75 years old when the INR is above therapeutic levels. The mechanism of how aging causes anticoagulant-related bleeding is not known.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/anticoagulant-treatment-canadian-healthcare-mall-researches.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Canadian health and care mall: Pregnancy</title>
		<link>http://www.diseases-illness.com/canadian-health-and-care-mall-pregnancy.html</link>
		<comments>http://www.diseases-illness.com/canadian-health-and-care-mall-pregnancy.html#comments</comments>
		<pubDate>Wed, 25 Feb 2015 13:44:43 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Canadian health care]]></category>
		<category><![CDATA[canadian health care mall]]></category>
		<category><![CDATA[canadian pharmacy mall]]></category>
		<category><![CDATA[pregnacy]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/?p=611</guid>
		<description><![CDATA[COMPLICATIONS I have read that mothers with diabetes are more likely to have babies with congenital malformations. I am thinking of a pregnancy but am terrified of having a child with an abnormality. What can I do to prevent this? It is true that there is an association between diabetes in the mother and congenital [&#8230;]]]></description>
				<content:encoded><![CDATA[<h1 style="text-align: center;">COMPLICATIONS</h1>
<p style="text-align: justify;"><b>I have read that mothers with diabetes are more likely to have babies with congenital malformations. I am thinking of a pregnancy but am terrified of having a child with an abnormality. What can I do to prevent this? <a href="http://www.diseases-illness.com/wp-content/uploads/2015/02/pregnancy.jpg"><img class="alignright size-medium wp-image-612" src="http://www.diseases-illness.com/wp-content/uploads/2015/02/pregnancy-300x200.jpg" alt="Pregnancy" width="300" height="200" /></a><br />
</b></p>
<p style="text-align: justify;">It is true that there is an association between diabetes in the mother and congenital abnormalities in her baby. We know that the most important factor influencing this is the control of the diabetes. If the HbA1c is less than 7.5% at conception, the risk of congenital abnormalities health and care mall is similar to that of mothers without diabetes. The higher the HbA1c, the greater the risk to the development of the baby. Therefore the best thing for you to do is to make sure that your diabetes is well controlled before you conceive.</p>
<p style="text-align: justify;">Some women with diabetes take regular medication to protect them from kidney and heart disease. These drugs can cause damage to the baby and should be stopped before you conceive. If you are uncertain about your medication you should discuss this with your doctor.</p>
<p style="text-align: justify;">There is good evidence that taking folic acid supplements before conception protects against abnormalities such as spina bifida and in people with diabetes the higher dose of 5 mg is recommended. Your doctor will prescribe this for you.</p>
<p style="text-align: justify;">All pregnant women are offered a blood test known as the triple test to screen for abnormalities such as Down’s syndrome and spina bifida. This is carried out at 16 weeks and if abnormal, further tests will be offered to identify the problem. If these confirm an abnormality, your doctors will discuss the implications with you, and you may decide to have a termination. Canadian health care mall online.</p>
<p style="text-align: justify;">Women with diabetes are also offered an abnormality scan at 20 weeks and this may be followed up with a detailed cardiac scan to identify any heart problems. If an abnormality is detected this will be discussed with you and a termination may be offered.</p>
<p style="text-align: justify;"><b>I developed toxaemia during my last pregnancy and had to spend several weeks in hospital even though control of my diabetes was immaculate. Luckily everything turned out all right and I now have a beautiful healthy son. Was the toxaemia related to me having diabetes? Is it likely to recur in future pregnancies?</b></p>
<p style="text-align: justify;">Women with diabetes are more prone to toxaemia (pre-eclampsia). You are not more likely to develop toxaemia in your future pregnancies &#8211; indeed the risk is lower than in your first pregnancy health and care pharmacy</p>
<p style="text-align: justify;"><b>During the recent delivery of my fourth child (which went very smoothly) I had an insulin pump into a vein during labour. I had not had this in my previous three pregnancies, despite having diabetes. Why did I need the pump this time?</b></p>
<p style="text-align: justify;">We now know that it is very important to keep your blood glucose within normal limits during labour to minimise the risk of your baby developing a low blood glucose (hypoglycaemia) in the first few hours after birth. This is most effectively and easily done using an intravenous insulin infusion combined with some glucose given as an intravenous drip. Using this method, your blood glucose can be kept strictly regulated at the normal level until your baby has been delivered. It also ensures that if any complications arise, an anaesthetic can be given without further preparation.</p>
<p style="text-align: justify;">Health and Care Website of the week: <a title="canadian health and care mall" href="http://www.acanadianhealthcaremall.com">www.acanadianhealthcaremall.com</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/canadian-health-and-care-mall-pregnancy.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Bonferroni method</title>
		<link>http://www.diseases-illness.com/the-bonferroni-method-in-canadian-pharmacy.html</link>
		<comments>http://www.diseases-illness.com/the-bonferroni-method-in-canadian-pharmacy.html#comments</comments>
		<pubDate>Tue, 11 Nov 2014 00:17:00 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Diseases]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/in-hospital-mortality-and-need-for-mv-at-any-point-during-the-hospitalization-served-as-co-primary-end-points.html</guid>
		<description><![CDATA[The designation into risk classes III, IV, and V are based on the whether the patient has one, two, or three of the central risk factors, respectively. We defined the occurrence of altered mental status as an initial Glasgow Coma score &#60; 14 or a designation by the physician of disorientation, stupor, or coma. End Points and Sensitivity Analyses In-hospital [&#8230;]]]></description>
				<content:encoded><![CDATA[<p style="text-align: justify;">T<strong>he designation into risk classes III, IV, and V are based on the whether the patient has one, two, or three of the central risk factors, respectively.</strong> We defined the occurrence of altered mental status as an initial Glasgow Coma score &lt; 14 or a designation by the physician of disorientation, stupor, or coma.</p>
<p style="text-align: justify;"><strong>End Points and Sensitivity Analyses</strong></p>
<p style="text-align: justify;">In-hospital mortality and need for MV at any point during the hospitalization served as co-primary end points. We further explored LOS and hospital costs relative to the BAP-65 score. Costs were computed by converting hospital charges by institution-specific cost-to-charge ratios obtained from the Centers for Medicare and Medicaid Services.</p>
<p style="text-align: justify;"><strong>Because both the timing of death and issues related to limitations in the intensity of care may affect resource use and LOS in hospitalized patients, we conducted a sensitivity analysis examining LOS and costs among only hospital survivors.</strong> By completing an evaluation of resource use in only survivors we aimed to limit confounding due to these concerns. In addition, we validated the BAP-65 in patients with principal diagnosis of AECOPD only, using the same definition as the one used for the original BAP-65 study.</p>
<p style="text-align: justify;"><span id="result_box" class="" lang="en"><span class="hps">Stay tuned for updates</span> <span class="hps">and subscribe to</span> <span class="hps">our <a title="canadian health and care mall" href="https://twitter.com/healthcare_mall">twitter</a>. Canadian health care news online)!</span></span></p>
<h3 style="text-align: justify;">Statistical Analysis</h3>
<p style="text-align: justify;">Categorical variables were compared with a x<sup>2</sup> test, and continuous variables were compared via analysis of variance. The Cochrane-Armitage trending statistic was used to assess whether the risk score could differentiate low-risk from high-risk patients in a fashion reflecting a graded response based on the level of risk present for mortality and MV use. <strong>For contrast test, we used x<sup>2</sup> test for categorical variable and Welch t test for continuous variables.</strong> We used the Bonferroni method to adjust for four follow-up tests of differences in each of the four end points from one BAP-65 class to the next. A P value of &lt; .0125 was considered statistically significant and all tests were two-sided. We assessed the predictive ability of the BAP-65 for the primary end points using the area under the receiver operating characteristic curve (AUROC). We constructed 95% CIs for the AUROC using 1,000 bootstrap iterations. We assessed sensitivity, specificity, and positive and negative predictive values of the BAP-65 for the primary end points.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/the-bonferroni-method-in-canadian-pharmacy.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Toxicomania and Sexuality</title>
		<link>http://www.diseases-illness.com/toxicomania-and-sexuality.html</link>
		<comments>http://www.diseases-illness.com/toxicomania-and-sexuality.html#comments</comments>
		<pubDate>Fri, 31 Oct 2014 16:03:00 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Sexual Health]]></category>
		<category><![CDATA[Toxicomania]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/?p=526</guid>
		<description><![CDATA[A scientific definition of the toxicomania, which will include its main chemical, pharmacological, physiopathological, psychotoxic characteristics and its medical-social implications, is hard to formulate. The World Health Organization (WHO), in the year 1952, based on a long study made by a group of experts which attended narcotics, elaborate the following definition: “Toxicomania is a state [&#8230;]]]></description>
				<content:encoded><![CDATA[<p style="text-align: justify;">A scientific definition of the toxicomania, which will include its main chemical, pharmacological, physiopathological, psychotoxic characteristics and its medical-social implications, is hard to formulate. The World Health Organization (WHO), in the year 1952, based on a long study made by a group of experts which attended narcotics, elaborate the following definition: “Toxicomania is a state of periodical or chronic intoxication, harmful for the individual and for the society, caused by the repeated use of a drug (natural or artificial) of which characteristics are the following: <img class="alignright size-medium wp-image-527" src="http://www.diseases-illness.com/wp-content/uploads/2014/10/image002-300x215.jpg" alt="Toxicomania" width="300" height="215" /></p>
<ul style="text-align: justify;">
<li>An invincible desire or a need to continue using the drug and to procure it by any means;</li>
<li>A tendency to increase the dosage;</li>
<li>An addiction of psychic order (psychological) and sometimes physical toward the effects of the drug&#8221;.</li>
</ul>
<p style="text-align: justify;">The notion of drug has a wider meaning and is not synonymous with the one of dope, even though in the Larousse dictionary it is defined this way: “the name given for dopes (cocaine, morphine); figurative: thing very bad to absorb&#8221;. In a wider meaning, the drug is any chemical substance that influences the living protoplasm. The dope is a substance that causes through repeated administration the specific phenomenon of pharmaco-addiction. The magazine “Sante du Monde&#8221; of the WHO determines that it must be considered a drug: “any substance (having or not legitimate medical applications) that makes the object of an abusive use in other purposes than medical”. Beside the specific actions over the central nervous system, over the psyche, for each group of drug addicts, it must be pointed out that all are accompanied by three phenomena: tolerance, pharmaco-addiction and the abstinence crisis.</p>
<p style="text-align: justify;"><em>Tolerance is a feeling that installs slowly and is explained through the reaction of adapting of the organism at the same dosage of drug administered repeatedly and as a consequence, the reaction of the organism diminishes at the same dosage of the.</em></p>
<p style="text-align: justify;">The pharmaco-addiction is a particular psychic state and often physical which results from the interaction between the living organism and a drug (medicine) which trains specific behavior modifications-an imperative need to continue using the drug, from the desire to reproduce its physical effects (and psychic). An individual can be addicted to several drugs.</p>
<p style="text-align: justify;">The pharmaco-addiction can be associated or not with the phenomenon of tolerance. The abstinence (the wean) represent a particular phenomenon, which appears generally after twelve-forty-eight hours from interrupting the administration of the drug and which causes for the toxicomaniac violent reactions: neuropsychological (nervousness, anxiety, insomnias), cardio-vascular disorders, until the state of collapse, such as at morphine addicts, muscular spasms, hyper-salivation, vomits, diarrhea. This state of crisis, which appears from the drug, is difficult to bear by the addict, which pushes him again toward the vice.</p>
<p style="text-align: justify;">Varenne tries a classification of the toxicomanias, based on three criteria: physical addiction, tolerance and psycho-toxicity, emphasizing their harmlessness, in descending order viagra online.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/toxicomania-and-sexuality.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hemorrhagic Complications of Anticoagulant Treatment</title>
		<link>http://www.diseases-illness.com/hemorrhagic-complications-of-anticoagulant-treatment-part-2.html</link>
		<comments>http://www.diseases-illness.com/hemorrhagic-complications-of-anticoagulant-treatment-part-2.html#comments</comments>
		<pubDate>Wed, 22 Oct 2014 00:19:25 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Treatment]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/hemorrhagic-complications-of-anticoagulant-treatment-part-2.html</guid>
		<description><![CDATA[WARSS = Warfarin-Aspirin Recurrent Stroke Study he major complication of anticoagulant therapy is bleeding. In this review, the incidence of hemorrhage in patients receiving oral anticoagulants or heparin and the clinical and laboratory risk factors that predispose to bleeding are discussed. The focus is on major bleeding and fatal bleeding. Details of the method used to select relevant articles can [&#8230;]]]></description>
				<content:encoded><![CDATA[<p style="text-align: justify;"><em>WARSS = Warfarin-Aspirin Recurrent Stroke Study he major complication of anticoagulant therapy is bleeding. In this review, the incidence of hemorrhage in patients receiving oral anticoagulants or heparin and the clinical and laboratory risk factors that predispose to bleeding are discussed.</em> The focus is on major bleeding and fatal bleeding. Details of the method used to select relevant articles can be found in the six previous sympo-sia<sup>1-6</sup> of the American College of DisIll Physicians and the chapter in this Supplement by Schiinemann et al. <img class="alignright size-full wp-image-522" src="http://www.diseases-illness.com/wp-content/uploads/2020/10/17211942_s-e1370642754595.jpg" alt="Anticoagulant Treatment" width="201" height="175" /></p>
<p style="text-align: justify;"><strong>Bleeding was generally classified as major if it was intracranial or retroperitoneal, if it led directly to death, or if it resulted in hospitalization or transfusion.</strong><sup>1</sup>’<sup>2</sup> However, there was variation between studies for the definition of bleeding. Although bleeding is the major side effect of anticoagulant therapy Viagra in Sydney, it should not be considered in isolation of potential benefit, ie, reduction in thromboembolism. <strong>This chapter focuses on bleeding related to vitamin K antagonists and heparins.</strong> In the section on vitamin K antagonists, risk factors for bleeding are first considered, and then bleeding rates for specific clinical conditions are presented. The same format is used for heparins. Bleeding related to new antithrombotic agents is also briefly discussed in a chapter by Weitz et al in this Supplement. The search and eligibility criteria used for our review are described in</p>
<p style="text-align: justify;">Table 1.</p>
<p style="text-align: justify;"><em><strong>1.0 Vitamin K Antagonists</strong></em></p>
<p style="text-align: justify;"><em><strong>1.1 Determinants of bleeding</strong></em></p>
<p style="text-align: justify;">The major determinants of oral vitamin K antagonist-induced bleeding are the intensity of the anticoagulant effect, patient characteristics, the concomitant use of drugs that interfere with hemostasis, and the length of therapy.</p>
<p style="text-align: justify;"><em><strong>1.1.1 Intensity of anticoagulant effect</strong></em></p>
<p style="text-align: justify;"><em>There is a strong relationship between the intensity of anticoagulant therapy and the risk of bleeding that has been reported in patients with deep vein thrombosis (DVT), tissue heart valves, mechanical heart valves, ischemic stroke, and atrial fibrillation.</em> In randomized clinical trials (RCTs) for these indications, the frequency of major bleeding in patients randomly assigned to warfarin therapy at a targeted international normalized ratio (INR) of approximately 2.0 to 3.0 has been less than half the frequency in patients randomly assigned to warfarin therapy at a targeted INR &gt; 3.0.</p>
<p style="text-align: justify;">The intensity of anticoagulant effect is probably the most important risk factor for intracranial hemorrhage, independent of the indication for therapy, with the risk increasing dramati- In five randomized trials in patients with atrial fibrillation, the annual incidence of major bleeding averaged 1.3% in patients randomly assigned to warfarin therapy (targeted INR generally 2.0 to 3.0), compared with 1.0% in patients randomly assigned to treatment with placebo. In patients with atrial fibrillation, an INR of 2.5 (range, 2.0 to 3.0) minimizes the risk of either hemorrhage or throm-boembolism. <em>Among patients with antiphospholipid antibody syndrome and prior thrombosis, the annual rate of major bleeding was similar in patients treated with warfarin at a targeted INR of 2.0 to 3.0, compared to those treated with warfarin at a targeted INR of 3.1 to 4.0 (3.0% vs 2.7%, respectively).</em></p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/hemorrhagic-complications-of-anticoagulant-treatment-part-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The results of the cost assessment paralleled the findings seen with LOS</title>
		<link>http://www.diseases-illness.com/the-results-of-the-cost-assessment-paralleled-the-findings-seen-with-los.html</link>
		<comments>http://www.diseases-illness.com/the-results-of-the-cost-assessment-paralleled-the-findings-seen-with-los.html#comments</comments>
		<pubDate>Tue, 14 Oct 2014 00:19:57 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Medicine]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/the-results-of-the-cost-assessment-paralleled-the-findings-seen-with-los.html</guid>
		<description><![CDATA[As was seen with the probability for both death and MV support, the LOS climbed as the BAP-65 class increased. Figure 3 displays the average LOS and 95% CIs by the BAP-65 class (F = 443.1; P &#60; .001) and P values for follow-up Welch t tests of differences in LOS from one class to the next. The results of [&#8230;]]]></description>
				<content:encoded><![CDATA[<p>A<em>s was seen with the probability for both death and MV support, the LOS climbed as the BAP-65 class increased. Figure 3 displays the average LOS and 95% CIs by the BAP-65 class (F = 443.1; P &lt; .001) and P values for follow-up Welch t tests of differences in LOS from one class to the next.<br />
</em></p>
<p>The results of the cost assessment paralleled the findings seen with LOS. For example, although the median costs were $5,357 (IQR, $3,479-$8,635) per admission, overall costs varied based on severity of illness buy Viagra online Australia and correlated closely with the BAP-65. For those in the lowest risk BAP-65 stratum (eg, no risk factors and age &lt; 65 years), median costs came to $4,307 (IQR, $2,879-$6,660), whereas costs nearly tripled for patients in BAP-65 highest risk cohort (median costs, $11,473; IQR, $5,988-$20,754). Figure 4 depicts average cost and 95% CIs by the BAP-65 class (F  = 1,049.6; P &lt; .001) and P values for follow-up Welch t tests of differences in cost from one class to the next.</p>
<p>The sensitivity analysis on LOS and cost restricted only to hospital survivors did not alter our observations regarding the relationship between resource use and the BAP-65 class. For example, the median LOS for all patients and for only hospital survivors both was 4 days. Among survivors, a longer LOS was associated with higher BAP-65 class and median LOS increases from 3 days (IQR, 2-5 days) in class I to 7 days in class V (IQR, 4-12 days). Costs showed similar relationship in the survivors. The median cost was $4,297 (IQR, $2,872-$6,607) vs $12,191(IQR, $6,929-$20,767) for patients in class I vs class V, respectively. The analysis on the primary end points by BAP-65 class in patients with the principal diagnosis of AECOPD yielded similar results (e-Appendix 1).</p>
<h2>Discussion with &#8220;HQ Pharmacy&#8221;</h2>
<p>This analysis of a large cohort of patients with AECOPDs demonstrates that the BAP-65 class correlates well with multiple clinical outcomes ranging from in-hospital mortality and need for MV to LOS and cost. Furthermore, the BAP-65 system identifies subjects unlikely to ever need MV.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/the-results-of-the-cost-assessment-paralleled-the-findings-seen-with-los.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hypertension, congestive heart failure, and diabetes mellitus</title>
		<link>http://www.diseases-illness.com/the-most-common-comorbidities-were-hypertension-congestive-heart-failure-and-diabetes-mellitus.html</link>
		<comments>http://www.diseases-illness.com/the-most-common-comorbidities-were-hypertension-congestive-heart-failure-and-diabetes-mellitus.html#comments</comments>
		<pubDate>Mon, 13 Oct 2014 00:18:25 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Diseases]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/the-most-common-comorbidities-were-hypertension-congestive-heart-failure-and-diabetes-mellitus.html</guid>
		<description><![CDATA[Results The final cohort included 34,669 subjects, of whom 80.6% had a principal diagnosis of AECOPD and the remainder had acute respiratory failure noted as the principal diagnosis along with COPD as a secondary diagnosis. As shown in Table 1, the median age was 72 years and 46.4% were men. The most common comorbidities were hypertension, congestive heart failure, and diabetes [&#8230;]]]></description>
				<content:encoded><![CDATA[<p style="text-align: justify;">Results</p>
<p style="text-align: justify;"><strong>The final cohort included 34,669 subjects, of whom 80.6% had a principal diagnosis of AECOPD and the remainder had acute respiratory failure noted as the principal diagnosis along with COPD as a secondary diagnosis.</strong> As shown in Table 1, the median age was 72 years and 46.4% were men. The most common comorbidities were hypertension, congestive heart failure, and diabetes mellitus.</p>
<p style="text-align: justify;">Approximately 4% of patients died while in the hospital, and MV was required at any point in 9.2%. We observed the pooled end point of either in-hospital mortality or ever needing MV in 11.2% of the population. Mortality rates increased with escalating BAP class (Fig 1A) (Cochran-Armitage trend test z = —38.48, P &lt; .001). Similarly, the use of MV (Fig 1B) escalated in a stepwise fashion as the score increased (Cochran-Armitage trend test z = —58.89, P&lt; .001). Follow-up x<sup>2</sup> tests and P values of differences in mortality and MV use from one class to the next can be found in Figures 1A and 1B, respectively.</p>
<p style="text-align: justify;">Figure 2 demonstrates the ROC curves for the BAP-65 system at predicting either death and/or application of MV. For the pooled end point of MV or mortality, the AUROC was 0.79 (95% CI, 0.78-0.80). The BAP-65 performed similarly at assessing each component of the pooled end point. For mortality, the AUROC equaled 0.77 (95% CI, 0.76-0.78), whereas it was 0.78 (95% CI, 0.78-0.79) for MV use.</p>
<p style="text-align: justify;">For the pooled end point, the cutoff point of class &gt; II, &gt; III, &gt; IV, or V corresponded to sensitivity ranging from 0.97 to 0.12, specificity ranging from 0.18 to 0.99, a positive predictive value ranging from 0.13 to 0.64, and a negative predictive value ranging from 0.98 to 0.90, respectively (Table 2).</p>
<p style="text-align: justify;">We observed a median LOS of 4 days (interquartile range [IQR], 3-7 days) with associated median costs of $5,357 (IQR, $3,479-$8,635). Among patients meeting no BAP-65 criteria, the median LOS was only 3 days (IQR, 2-5 days). The median LOS more than doubled (median of 7 days; IQR, 3-11 days) in the most severely ill subjects who had all BAP-65 conditions.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/the-most-common-comorbidities-were-hypertension-congestive-heart-failure-and-diabetes-mellitus.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Erectile Dysfunction health</title>
		<link>http://www.diseases-illness.com/the-erectile-dysfunction-health.html</link>
		<comments>http://www.diseases-illness.com/the-erectile-dysfunction-health.html#comments</comments>
		<pubDate>Mon, 06 Oct 2014 13:33:20 +0000</pubDate>
		<dc:creator><![CDATA[Dan Frost]]></dc:creator>
				<category><![CDATA[Erectile Dysfunction]]></category>

		<guid isPermaLink="false">http://www.diseases-illness.com/?p=501</guid>
		<description><![CDATA[A provincial asthma education network leading to the establishment of more than a hundred AECs was established in the 1990s in the province of Quebec. Unfortunately, only a small proportion of asthmatic patients consulting for acute asthma were initially directed to AECs, so we looked at strategies to increase the number of patients seen at [&#8230;]]]></description>
				<content:encoded><![CDATA[<p>A provincial asthma education network leading to the establishment of more than a hundred AECs was established in the 1990s in the province of Quebec. Unfortunately, only a small proportion of asthmatic patients consulting for acute asthma were initially directed to AECs, so we looked at strategies to increase the number of patients seen at these centers. A model of automatic referral of asthmatic patients to an AEC had been developed at Laval Hospital, and preliminary results had been positive, with a reduction of ED visits in the subsequent months. To get more asthmatic patients who were consulting for acute asthma into structured educational Canadian Pharmacy interventions, we developed a new program, subsequently supported by the Canadian Fund for Adaptation of Health Services. This program offers a model of educational intervention and follow-up strategies for acute care centers (ACCs). It is aimed at promoting participation of patients with asthma in such educational programs as the ones offered by established AECs of the Quebec Asthma Education Network; the idea is to make systematic and voluntary referrals to those centers. This article describes the above model and includes an evaluation of its impact on referrals to an AEC, as well identifying factors that influence, either positively or negatively, the implementation of such programs.</p>
<h3>Materials and Methods CAnadian pharmacy viagra</h3>
<p>The program described here aimed at increasing referrals of asthmatic patients consulting at the ED Viagra in Australia or admitted to the hospital for acute asthma to specialized asthma educators in AECs. Its specific goals were to integrate into current care the systematic referral of asthmatic patients to an AEC by the ED staff. Another goal, not formally evaluated in the present analysis, was to initiate a short educational intervention at the ED that would increase patients’ basic knowledge of asthma and, most importantly, motivate them to pursue the educational program.</p>
<p>To achieve the above goals in each center, we proposed two main types of interventions. First, the ED health professionals would be given specific training on asthma and its treatment, the appropriate use of inhalers, and the role of an AEC.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.diseases-illness.com/the-erectile-dysfunction-health.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
